The role of dyslipidemia and statins in venous thromboembolism

AUTOR(ES)

Ray, Joel G

FONTE

BioMed Central

RESUMO

Recent studies have proposed an association between hyperlipidemia and venous thromboembolism (VTE). We review the epidemiological evidence linking dyslipidemia with VTE and examine several possible underlying mechanisms. We discuss the possible role of HMG CoA reductase inhibitors (statins) in the prevention and treatment of VTE and suggest future directions for research.

Documentos Relacionados

• Venous thromboembolism in stroke.
• Venous thromboembolism in coronary artery surgery.
• Assessing Risk of Venous Thromboembolism in the Patient With Cancer
• Low-molecular-weight heparins in the treatment of venous thromboembolism
• The weak connection between venous thromboembolism and air travel